| |
| |
|
| Insider
Information: |
Cox Russell J. |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
117,021 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,243,200 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
117,021 |
|
|
| Total
Value |
$11,243,200 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Jazz Pharmaceuticals Inc |
JAZZ |
EVP & COO |
2017-12-11 |
102,821 |
2011-05-31 |
0 |
Premium* |
|
|
Aeglea Biotherapeutics, Inc. |
AGLE |
Director |
2016-04-12 |
7,000 |
2016-04-12 |
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
Director |
2019-02-12 |
7,200 |
2019-02-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2012-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
19,005 |
19,005 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2012-01-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(19,005) |
0 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2012-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
50,012 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
59,769 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2014-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
60,024 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Operating Officer |
• – – |
2014-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
64,532 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,675 |
68,072 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
67,690 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
54,588 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2011-05-31 |
4 |
A |
$14.89 |
$3,097 |
D/D |
208 |
208 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-05-20 |
5 |
OE |
$8.23 |
$8,230 |
D/D |
1,000 |
54,024 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
SVP, Sales and Marketing |
• – – |
2011-11-30 |
4 |
A |
$14.89 |
$14,994 |
D/D |
1,007 |
1,215 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2012-05-31 |
4 |
A |
$14.89 |
$14,994 |
D/D |
1,007 |
15,012 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-05-20 |
4 |
AS |
$58.54 |
$58,540 |
D/D |
(1,000) |
58,769 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Director |
– • – |
2016-04-12 |
4 |
B |
$10.00 |
$70,000 |
D/D |
7,000 |
7,000 |
2.39 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-03-05 |
4 |
S |
$175.10 |
$87,550 |
D/D |
(500) |
65,053 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-09-04 |
4 |
AS |
$88.16 |
$88,160 |
D/D |
(1,000) |
52,736 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2015-08-11 |
4 |
AS |
$177.82 |
$88,910 |
D/D |
(500) |
58,602 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2015-04-14 |
4 |
AS |
$181.45 |
$90,725 |
D/D |
(500) |
64,553 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-02-26 |
4 |
D |
$125.00 |
$91,375 |
D/D |
(731) |
66,959 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-02-29 |
4 |
D |
$121.58 |
$114,164 |
D/D |
(939) |
66,020 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
Director |
– • – |
2019-02-12 |
4 |
B |
$16.00 |
$115,200 |
D/D |
7,200 |
7,200 |
2.39 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2016-08-07 |
4 |
D |
$149.02 |
$145,742 |
D/D |
(978) |
59,603 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & COO |
• – – |
2017-08-07 |
4 |
D |
$155.56 |
$152,138 |
D/D |
(978) |
51,985 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
EVP & Chief Commercial Officer |
• – – |
2013-08-01 |
4 |
AS |
$76.22 |
$152,440 |
D/D |
(2,000) |
57,046 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
